A patient specific case scenario on advanced lung cancer in a situation involving a patient that has never been a smoker with lung adenocarcinoma that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on clinical decisions. Patient progression reveals:' Decisions in treatment and tests through disease stages' Factors influencing their decisions' Barriers to optimal patient care' Confidence in treatment Data has been synthesized to show all responses and direct quotes from the oncologists. This is the primary research for the oncology prescribing data that you are missing - directly from high-prescribing US oncologists on Advanced Lung Cancer. Treatment decisions for advanced stages of lung cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists' choices. This report is part of a series of oncology reports that allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer. This report allows you to:' Understand what occurs with actual patients' Access the most up-to-date prescribing trends' Gain actionable data for developing and improving your market strategies' Pinpoint needs of your target audience' Focus resources to maximize the effectiveness of your budget' Understand where your product fits' Understand where your competitor's product fits' Design messages to advance brand performance

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Advanced Lung Cancer in a Never Smoker with Lung
Adenocarcinoma: Clinical Insights from a US Oncologists' Survey
Published on April 2011
Report Summary
A patient specific case scenario on advanced lung cancer in a situation involving a patient that has never been a smoker with lung
adenocarcinoma that progresses throughout the report, presented to 158 high-prescribing oncologists for their open responses on
clinical decisions. Patient progression reveals:
' Decisions in treatment and tests through disease stages
' Factors influencing their decisions
' Barriers to optimal patient care
' Confidence in treatment
Data has been synthesized to show all responses and direct quotes from the oncologists. This is the primary research for the
oncology prescribing data that you are missing - directly from high-prescribing US oncologists on Advanced Lung Cancer.
Treatment decisions for advanced stages of lung cancer are difficult to track as information quickly changes along with the
introduction of new products that all have an impact oncologists' choices. This report is part of a series of oncology reports that allow
you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in
advanced stages of cancer.
This report allows you to:
' Understand what occurs with actual patients
' Access the most up-to-date prescribing trends
' Gain actionable data for developing and improving your market strategies
' Pinpoint needs of your target audience
' Focus resources to maximize the effectiveness of your budget
' Understand where your product fits
' Understand where your competitor's product fits
' Design messages to advance brand performance
Table of Content
Table of contents
Executive Summary5
Chapter 1: Introduction7
Table 1: Treatment Options in Advanced Lung Cancer7
Chapter 2: Respondent Demographics9
Table 2: Eligibility Criteria for Survey Participation9
Figure 2.1 Gender of Survey Respondents9
Advanced Lung Cancer in a Never Smoker with Lung Adenocarcinoma: Clinical Insights from a US Oncologists' Survey (From Slideshare) Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Figure 2.2 Years since Medical School Graduation10
Figure 2.3 Practice Settings10
Figure 2.4 Practices in NCI Cancer Centers11
Figure 2.5 Geographic Settings11
Figure 2.6 Survey Respondents by State's Lung Cancer Mortality12
Figure 2.7 Number of Physicians in Practice Groups13
Figure 2.8 Minimal Acceptable Level of Evidence in Determining Treatment Regimen13
Chapter 3: Treatment of a Never Smoker with Adenocarcinoma14
Figure 3.1 Laboratory studies to order14
Figure 3.2 Confidence in treating patient to an optimal outcome15
Figure 3.3 Next step in management16
Figure 3.4 Whether to wait for results of testing before beginning systemic therapy17
Figure 3.5 First-line chemotherapy regimen18
Figure 3.6 Factors influencing treatment decision20
Figure 3.7 Barriers to management of advanced lung cancer22
Chapter 4: Summary24
Appendix A: Survey Instrument25
Advanced Lung Cancer in a Never Smoker with Lung Adenocarcinoma: Clinical Insights from a US Oncologists' Survey (From Slideshare) Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Advanced Lung Cancer in a Never Smoker with Lung Adenocarcinoma: Clinical Insights from a US Oncologists' Surv
ey
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 2 999.00 Quantity: _____
CD-ROM--USD 2 999.00 Quantity: _____
Hard Copy--USD 2 999.00 Quantity: _____
Corporate License--USD 4 999.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Advanced Lung Cancer in a Never Smoker with Lung Adenocarcinoma: Clinical Insights from a US Oncologists' Survey (From Slideshare) Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Advanced Lung Cancer in a Never Smoker with Lung Adenocarcinoma: Clinical Insights from a US Oncologists' Survey (From Slideshare) Page 4/4